Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Edition
European
US
Rheumatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
The first and only approved dual inhibitor of IL-17A and IL-17F1-6
February 2026
BIMZELX® Demonstrated Deep and Sustained Efficacy to 3 Years Across Multiple Disease Domains of PsA and the Full axSpA Spectrum…
Read more
8
Mins
14 Jul 2022
Editor’s Pick: Paediatric Scleroderma: Kids Are Not Just Little Adults
The sclerodermas are a family of autoimmune rheumatic diseases characterised by activation of the adaptive and innate immune system, genetic and vascular involvement…
3
Mins
14 Jul 2022
EULAR 2022 Congress Interview: Xenofon Baraliakos
Well, there are different arguments for pursuing a career in rheumatology. There are people who want to work more clinically…
9
Mins
14 Jul 2022
Type I Interferons in the Pathogenesis and Treatment of Sjögren's Syndrome: An Update
Interferons (IFN) are a class of cytokines that are produced in response to pathogenic stimuli.1 The IFN family was divided into three classes: Type I, Type II, and Type III…
4
Mins
14 Jul 2022
Interview: Jeffrey A. Sparks
I confess that serendipity was a main driver of my career path. In college, I was a physics major with an interest in humanities…
10
Mins
14 Jul 2022
Metabolic Syndrome and its Outcomes in Rheumatoid Arthritis: A Review
Metabolic syndrome is a cluster of health conditions linked to increased cardiovascular disease. It is found worldwide in increasing…
2
Mins
14 Jul 2022
Interview: Lorinda Chung
My father is a physician and served as an inspiration for me and my three older sisters to go into medicine. Having attended…
7 Jul 2022
IME Rheumatology Webinar | Key Insights from EULAR 2022 - An Interdisciplinary Expert Roundtable Discussion
Watch our roundtable discussion to gain a deeper understanding of emerging data from the EULAR 2022 congress.
1 Jul 2022
Ultrasound Imaging and Its Applications in Rheumatology
This podcast focuses on the latest evidence supporting the use of ultrasound in diagnosis within rheumatology with a special focus on rheumatoid arthritis.
Loading posts...
« Previous
1
…
42
43
44
45
46
…
83
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View